Leukemia

• 

  Subject Areas on Research

  • 5-Azacitidine Monotherapy Followed by Related Haploidentical Hematopoietic Stem Cell Transplantation Achieves Durable Remission in a Pediatric Patient With Acute Undifferentiated Leukemia Refractory to High-Dose Chemotherapy. 
  • A Bayesian approach to joint feature selection and classifier design. 
  • A Systematic Review of Psychometric Properties of Health-Related Quality-of-Life and Symptom Instruments in Adult Acute Leukemia Survivors. 
  • A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy. 
  • A complex role for Bcl10 in kidney injury. 
  • A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group B. 
  • A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. 
  • A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. 
  • A nonparametric empirical Bayes framework for large-scale multiple testing 
  • A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes. 
  • A novel chromosomal rearrangement associated with therapy-related acute leukemia. 
  • A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance). 
  • A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy. 
  • A quantitative analysis of palliative care decisions in acute nonlymphocytic leukemia. 
  • A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. 
  • ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia. 
  • Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia. 
  • Activities and accomplishments of the cancer and leukemia group B genitourinary committee. 
  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. 
  • Acute leukemia in Burkitt lymphoma. 
  • Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study. 
  • Aging and neoplasia. 
  • Air crescent sign of invasive aspergillosis. 
  • Allogeneic marrow transplantation for acute leukemia in relapse. 
  • Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. 
  • Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. 
  • Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. 
  • Allogeneic marrow transplantation. 
  • Alzheimer's disease: genetic aspects and associated clinical disorders. 
  • Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. 
  • Analysis of late infections in 89 long-term survivors of bone marrow transplantation. 
  • Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells. 
  • Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. 
  • Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. 
  • Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. 
  • Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. 
  • Aspergillus-induced small bowel obstruction in a leukemic newborn. 
  • Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. 
  • Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial. 
  • Association of the human type C retrovirus with a subset of adult T-cell cancers. 
  • Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. 
  • B lymphocytes: how they develop and function. 
  • B-cell lymphosarcoma cell leukemia: dynamics of surface-membrance immunoglobulin. Value for differentiation from chronic lymphocytic leukemia. 
  • BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis. 
  • BP1, a new homeobox gene, is frequently expressed in acute leukemias. 
  • Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. 
  • Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development. 
  • Bone marrow transplantation for hematologic malignancies: the Stanford experience. 
  • Bone marrow transplantation in patients aged 45 years and older. 
  • Bone marrow transplantation. Part II--autologous. 
  • Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. 
  • Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study. 
  • Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. 
  • Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. 
  • Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. 
  • CT scans in childhood and risk of leukaemia and brain tumours. 
  • Cancer and leukemia group B gastrointestinal cancer committee. 
  • Cancer in pregnancy: a review of the literature. Part II. 
  • Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole. 
  • Candidate counterparts of Sézary cells and adult T-cell lymphoma-leukaemia cells in normal peripheral blood: an ultrastructural study with the immunogold method and monoclonal antibodies. 
  • Carcinocythemia (carcinoma cell leukemia). 
  • Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis. 
  • Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. 
  • Changes in macrophages and their functions with aging in C57BL/6J, AKR/J, and SJL/J mice. 
  • Chemotherapy and the bone marrow stroma. 
  • Childhood Cancer Symptom Cluster: Leukemia and Health-Related Quality of Life. 
  • Childhood Leukemia, Late Effects, and a Person-centric Model of Follow-up. 
  • Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. 
  • Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. 
  • Clinical implications of aneuploid cytogenetic profiles in adult acute leukemia. 
  • Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. 
  • Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. 
  • Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies. 
  • Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies. 
  • Comparison of prednisolone, vincristine, methotrexate, and 6-mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia. 
  • Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. 
  • Cost effectiveness of myeloid growth factors in cancer chemotherapy. 
  • Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. 
  • Course of Crohn's disease after allogeneic marrow transplantation. 
  • Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). 
  • Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia. 
  • Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. 
  • Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. 
  • Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. 
  • Declines Noted in Cognitive Processes and Association With Achievement Among Children With Leukemia. 
  • Delayed myonecrosis in a leukemic patient with invasive group A streptococcal disease. 
  • Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells. 
  • Design and evaluation of leukaemia trials. 
  • Detection and partial characterization of human thymus-leukemia antigens. 
  • Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. 
  • Disseminated infection with rapidly growing mycobacteria. 
  • Distress in patients with acute leukemia: a concept analysis. 
  • Does thalidomide affect IL-2 response and production? 
  • Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. 
  • Early deaths in newly diagnosed cases of pediatric acute leukemia: a Southwest Oncology Group Study. 
  • Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B. 
  • Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. 
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. 
  • Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice. 
  • Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice. 
  • Effect of thimerosal in leukemia, in leukemic cell lines, and on normal hematopoiesis. 
  • Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. 
  • Effects of continuous or discontinuous maintenance therapy on subsequent remission maintenance in childhood leukemia. 
  • Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools. 
  • Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow. 
  • Endocytosis and recycling of the T3-T cell receptor complex. The role of T3 phosphorylation. 
  • Endocytosis proteins and cancer: a potential link? 
  • Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells. 
  • Enzymatic studies in the different types of normal and leukemic human white cells. 
  • Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. 
  • Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. 
  • Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation. 
  • Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia. 
  • Evaluation of microRNA expression in patient bone marrow aspirate slides. 
  • Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. 
  • Fatigue and Oxidative Stress in Children Undergoing Leukemia Treatment. 
  • Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. 
  • Fibrinogen kinetics in patients with neoplastic disease. 
  • Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia. 
  • Follicular mucinosis as a presenting sign of acute myeloblastic leukemia. 
  • Formaldehyde and leukemia: epidemiology, potential mechanisms, and implications for risk assessment. 
  • Gaining insights into chronic natural killer cell leukemias through extensive characterization of an individual case. 
  • Genetic dissection of leukemia-associated IDH1 and IDH2 mutants and D-2-hydroxyglutarate in Drosophila. 
  • Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. 
  • Gordon's first law. 
  • Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. 
  • Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. 
  • Graft-versus-host reactions: anti-leukemia effects of donor T cells. 
  • Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. 
  • Growth and development following marrow transplantation for leukemia. 
  • Haploidentical transplantation for leukemia. 
  • Hematopoietic growth factors in the reduction of chemotherapeutic toxicity. 
  • High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study. 
  • High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia. 
  • High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. 
  • Hospital charges and length of stay associated with septicemia among children hospitalized for leukemia treatment in the United States. 
  • Human acute leukemia cells with membrane-bound immunoglobulin. 
  • Human herpesvirus 6 limbic encephalitis after stem cell transplantation. 
  • Human leukemia antigens: partial isolation and characterization. 
  • Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters. 
  • Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression. 
  • Human melanoma and leukemia associated antigens difined by nonhuman primate antisera. 
  • I and i antigens on normal and leukemic leukocytes. 
  • Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. 
  • Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. 
  • Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. 
  • Improving end-of-life care for patients with leukemia: is inpatient death the right measure? 
  • In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. 
  • Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine. 
  • Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic. 
  • Infection with varicella-zoster virus after marrow transplantation. 
  • Influence of Inflammatory and Oxidative Stress Pathways on Longitudinal Symptom Experiences in Children With Leukemia. 
  • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. 
  • Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity. 
  • Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias. 
  • Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein. 
  • Intraluminal thrombus and bowel obstruction in acute leukemia due to bleeding Meckel's diverticulum. 
  • Introduction. 
  • Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. 
  • Late complications of allogeneic and autologous marrow transplantation. 
  • Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. 
  • Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. 
  • Letter: Incidence of childhood leukaemia. 
  • Letter: Role of reverse transcriptase. 
  • Leukaemia: a model metastatic disease. 
  • Leukemia cutis in a patient with chronic neutrophilic leukemia. 
  • Leukemia in twins. 
  • Leukemia-associated arthritis: identification of leukemic cells in synovial fluid using monoclonal and polyclonal antibodies. 
  • Leukemia/lymphoma in cerebrospinal fluid: distinguishing between cases that performed well and poorly in the College of American Pathologists Interlaboratory Comparison Program in Non-gynecologic Cytology. 
  • Leukemia: an overview for primary care. 
  • Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. 
  • Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. 
  • Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia. 
  • Long-term results of allogeneic bone marrow transplantation. 
  • Long-term results of reinforcement therapy in children with acute leukemia. 
  • Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. 
  • Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events. 
  • Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection. 
  • Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. 
  • Management of febrile neutropenia in a patient with acute leukemia. 
  • Management of leukemic hyperleukocytosis with hydration, urinary alkalinization, and allopurinol. Are cranial irradiation and invasive cytoreduction necessary? 
  • Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. 
  • Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. 
  • Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease. 
  • Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. 
  • Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. 
  • Medical paternalism or legal imperialism: not the only alternatives for handling Saikewicz-type cases. 
  • Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes. 
  • Metabolism of ara-C by blast cells from patients with ANLL. 
  • Methods for the analysis of histone H3 and H4 acetylation in blood. 
  • Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. 
  • Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. 
  • Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow. 
  • Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV. 
  • Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II. 
  • Mortality reporting for childhood leukemia. 
  • Multiple myeloma and family history of cancer. A case-control study. 
  • Mycobacterial infections in marrow transplant patients. 
  • New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. 
  • Nonketotic hyperglycemia due to prednisone (NSC-10023) following ketotic hyperglycemia due to L-asparaginase (NSC-109229) plus prednisone. 
  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. 
  • Ocular involvement in congenital leukemia. 
  • Ocular manifestations of hematologic disorders. 
  • Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. 
  • Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data. 
  • Oral manifestations of chronic graft-v-host disease. 
  • Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells. 
  • Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. 
  • Outcomes among 562 recipients of placental-blood transplants from unrelated donors. 
  • Ovarian function following marrow transplantation for aplastic anemia or leukemia. 
  • Paediatric leukaemia DNA methylation profiling using MBD enrichment and SOLiD sequencing on archival bone marrow smears. 
  • Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance). 
  • Patient perspectives on physical function after allogeneic hematopoietic stem cell transplantation: a qualitative study. 
  • Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire. 
  • Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia. 
  • Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. 
  • Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. 
  • Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia. 
  • Phase I-II trial of mitoxantrone in acute leukemia: an interim report. 
  • Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. 
  • Phenotypic and functional characterization of human malignant T cells. 
  • Physical Activity, the Childhood Cancer Symptom Cluster-Leukemia, and Cognitive Function: A Longitudinal Mediation Analysis. 
  • Physiologic and psychological symptoms experienced by adults with acute leukemia: an integrative literature review. 
  • Plant Antitumor Agents. VI. The Isolation and Structure of Taxol, a Novel Antileukemic and Antitumor Agent from Taxus brevifolia 
  • Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer. 
  • Poor Oral Health Linked with Increased Risk of Infectious Complications in Adults with Leukemia. 
  • Practical Strategies for Optimizing and Integrating Palliative Care in Cancer. 
  • Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. 
  • Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. 
  • Programmed cell death induced by ceramide. 
  • Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3. 
  • Purging multidrug resistant cells from bone marrow. 
  • RIPK3 Slams the Brake on Leukemogenesis. 
  • Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. 
  • Regulated expression of p18, a major phosphoprotein of leukemic cells. 
  • Regulation of leukocyte adhesion molecule-1 (TQ1, Leu-8) expression and shedding by normal and malignant cells. 
  • Relatedness by nucleic acid hybridization of new isolates of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of provirus in uncultured leukemic blood cells. 
  • Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. 
  • Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. 
  • Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemia. 
  • Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. 
  • Rheumatologic manifestations of cancer. 
  • Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. 
  • Role of ABL family kinases in cancer: from leukaemia to solid tumours. 
  • Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. 
  • Role of the ABL oncogene tyrosine kinase activity in human leukaemia. 
  • Rubidazone in the treatment of recurrent acute leukemia in children. A Pediatric Oncology Group Study. 
  • Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. 
  • Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. 
  • Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. 
  • Self-administration of morphine in bone marrow transplant patients reduces drug requirement. 
  • Sorting multiple classes in multi-dimensional ROC analysis: parametric and nonparametric approaches. 
  • Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. 
  • Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species. 
  • Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program. 
  • State of the art in umbilical cord transplantation. 
  • Statistical considerations for analysis of microarray experiments. 
  • Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia. 
  • Stimulation of clonal tumor cell growth in vitro by inhibiting the serum polyamine oxidase activity. 
  • Stimulation of the T3-T cell receptor complex induces a membrane-potential-sensitive calcium influx. 
  • Studies of ara-C metabolism in acute leukemia. 
  • Suppressing oncogenic transcription with a little healthy competition. 
  • Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405. 
  • Symptom Clusters, Physical Activity, and Quality of Life: A Latent Class Analysis of Children During Maintenance Therapy for Leukemia. 
  • Symptom Trajectories in Children Receiving Treatment for Leukemia: A Latent Class Growth Analysis With Multitrajectory Modeling. 
  • Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine. 
  • Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth. 
  • Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect. 
  • Targeting PDGF receptors in cancer--rationales and proof of concept clinical trials. 
  • Thalidomide as salvage therapy for chronic graft-versus-host disease. 
  • The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). 
  • The French-American-British (FAB) classification of leukemia. The Pediatric Oncology Group experience with lymphocytic leukemia. 
  • The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies. 
  • The Role of Granulocyte Transfusions in Optimizing Candidacy for Chimeric Antigen Receptor T-cell Therapy in Patients With Treatment-refractory Infections. 
  • The cancer and leukemia group B cancer in the elderly committee: addressing a major cancer need. 
  • The complexity of chronic disease at later ages: practical implications for prospective payment and data collection. 
  • The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. 
  • The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. 
  • The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment. 
  • The pathophysiology and treatment of graft-versus-host disease. 
  • The role of hematopoietic growth factors and oncogenes in leukemogenesis. 
  • The tumor dormant state. 
  • The use of Grade of Membership analysis to evaluate and modify diagnosis-related groups. 
  • The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system. 
  • The use of non-human primates for production of antisera to human tumor-associated antigens. 
  • Thromboembolism in hospitalized neutropenic cancer patients. 
  • Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans. 
  • To Match or Not to Match in Cord Blood Transplantation: A Modern Look at a Recurring Question. 
  • Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B. 
  • Towards a genomic-based diagnosis. 
  • Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. 
  • Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation. 
  • Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. 
  • Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. 
  • Transplantation without pretransplant therapy: Is this a possibility? Insights into providing transplantation at diagnosis for patients with acute leukemia. 
  • Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. 
  • Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study. 
  • Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. 
  • Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. 
  • Unfavorable prognosis of acute leukemia in infancy. 
  • Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. 
  • Unrelated donor marrow transplantation in children. 
  • Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up. 
  • Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). 
  • Virtual reality as a distraction intervention for older children receiving chemotherapy. 
  • What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? 
  • Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States. 
  • Wolman Disease: A Mimic of Infant Leukemia. 
  • [THE ENZYMES OF THE LEUKOCYTE]. 
• 

  Keywords of People

  • Carrillo, Luis Felipe, Assistant Professor of Pathology, Pathology
  • Erba, Harry Paul, Professor of Medicine, Duke Cancer Institute
  • Hong, Sanghee, Assistant Professor of Medicine, Duke Cancer Institute
  • Krangel, Michael S., George Barth Geller Distinguished Professor of Immunology, Integrative Immunobiology
  • LeBlanc, Thomas William, Associate Professor of Medicine, Duke Cancer Institute
  • Young, Ken H, Professor of Pathology, Pathology